Metabolism of chlorpyrifos and chlorpyrifos oxon by human hepatocytes

被引:38
作者
Choi, Kyoungju [1 ]
Joo, Hyun [1 ]
Rose, Randy L. [1 ]
Hodgson, Ernest [1 ]
机构
[1] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA
基金
美国国家卫生研究院;
关键词
chlorpyrifos; chlorpyrifos oxon; cytochrome P450; phase II metabolism; glutathione; glucuronide; LC-MS/MS; human hepatocytes; human liver S9 fraction;
D O I
10.1002/jbt.20145
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The metabolism of chlorpyrifos (CPS) and chlorpyrifos oxon (CPO) by human hepatocytes and human liver S9 fractions was investigated using LC-MS/MS. Cytochrome P450 (CYP)-dependent and phase II-related products were determined following incubation with CPS and CPO. CYP-related products, 3,5,6-trichloro-2-pyridinol (TCP), diethyl thiophosphate, and dealkylated CPS, were found following CPS treatment and dealkylated CPO following CPO treatment. Diethyl phosphate was not identified because of its high polarity and lack of retention with the chromatographic conditions employed. Phase II-related conjugates, including 0- and S-glucuronides as well as 11 GSH-derived metabolites, were identified in CPS-treated human hepatocytes, although the O-sulfate of TCP conjugate was found only when human liver S9 fractions were used as the enzyme source. O-Glucuronide of TCP was also identified in CPO-treated hepatocytes. CPS and CPO were identified using HPLC-UV after CPS metabolism by the human liver S9 fraction. However, CPO was not found following treatment of human hepatocytes with either CPS or CPO. These results suggest that human liver plays an important role in detoxification, rather than activation, of CPS. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:279 / 291
页数:13
相关论文
共 29 条
[1]
Pharmacokinetic profile and placental transfer of a single intravenous injection of [14C]chlorpyrifos in pregnant rats [J].
Abdel-Rahman, AA ;
Blumenthal, GM ;
Abou-Donia, SA ;
Ali, FAF ;
Abdel-Monem, AE ;
Abou-Donia, MB .
ARCHIVES OF TOXICOLOGY, 2002, 76 (08) :452-459
[2]
[Anonymous], 2004, TXB MODERN TOXICOLOG
[3]
BAKKE JE, 1976, J ENV SCI HLTH B, V3, P225
[4]
CHLORPYRIFOS PHARMACOKINETICS AND METABOLISM FOLLOWING INTRAVASCULAR AND DIETARY ADMINISTRATION IN CHANNEL CATFISH [J].
BARRON, MG ;
PLAKAS, SM ;
WILGA, PC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (03) :474-482
[5]
Determination of chlorpyrifos metabolites in human urine by reversed-phase/weak anion exchange liquid chromatography-electrospray ionisation-tandem mass spectrometry [J].
Bicker, W ;
Lämmerhofer, M ;
Lindner, W .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 822 (1-2) :160-169
[6]
A case study of acute human chlorpyrifos poisoning:: Novel aspects on metabolism and toxicokinetics derived from liquid chromatography-tandem mass spectrometry analysis of urine samples [J].
Bicker, W ;
Lämmerhofer, M ;
Genser, D ;
Kiss, H ;
Lindner, W .
TOXICOLOGY LETTERS, 2005, 159 (03) :235-251
[7]
Bomser J, 2000, J BIOCHEM MOL TOXIC, V14, P346, DOI 10.1002/1099-0461(2000)14:6<346::AID-JBT7>3.0.CO
[8]
2-H
[9]
Choi Jonghoon, 2004, Drug Metabolism and Drug Interactions, V20, P233
[10]
ROLE OF ALIESTERASE IN ORGANO-PHOSPHATE POISONING [J].
CLEMENT, JG .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1984, 4 (02) :S96-S105